Soley Therapeutics

About Soley Therapeutics

Soley Therapeutics is a science-first, tech-enabled drug discovery and development company that uses human cells as powerful sensors to uncover first-in-class medicines. Their proprietary imaging, AI, and automation technologies translate whole cell information into innovative treatments for complex diseases with speed and scale.

Products & Services

Drug Discovery Platform:A biology-first platform that maps whole-cell sensing to uncover novel biology and guide precise drug discovery for complex diseases.

Pipeline of Medicines:Advancing innovative, first-in-class medicines with new mechanisms targeting oncology and non-oncology complex diseases.

Specialties

Drug Discovery Cell-Based Sensing AI and Automation in Medicine Oncology Non-Oncology Complex Diseases

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C T: - FT: Series C	A: 200000000 MR: - FA: $200 million FAN: 200000000	D: 2026-01-07 FD: 2026-01-07	6 investors

Series C Latest

2026-01-07

$200.0M

6 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

Y

Yerem Yeghiazarians

Co-Founder and Chief Executive Officer

K

Kurosh Ameri

Co-Founder and Chief Scientific Officer

P

Paul Woodard

Pediatric Hematologist-Oncologist and Stem Cell Transplant Physician

S

Sheerin Latham

Ph.D.

E

Erik Wiberg

CBO, Acting CFO

M

Mehrdad Hamadani

Chief Technology Officer, EVP Engineering, AI, and Operations

View 4 more team members with Pro

Unlock Full Team Directory

Recent News